Sonia Garcia

Comparing Spravato vs ketamine infusion treatment means comparing two versions of the same idea: using ketamine's fast action on the brain's glutamate system to treat depression that standard antidepressants haven't relieved. The best comparison so far, a 2025 meta-analysis by Mayo Clinic researchers, found no statistically significant difference in how often the two lead to response or remission. What separates them is everything around the drug: FDA status, how it's given, how quickly it tends to work, what it costs, and who pays.

‍

So far, neither has been shown to be the better drug.

What Is Spravato (Esketamine)?

Esketamine vs ketamine comes down to chemistry. Standard ketamine is an equal mix of two mirror-image forms of the same molecule. Esketamine is one of those forms on its own, and Spravato is esketamine delivered as a nasal spray.

‍

The FDA first approved Spravato in 2019 for treatment-resistant depression, taken together with an oral antidepressant, as the Mayo Clinic review notes. A second approval, again paired with an oral antidepressant, covers depressive symptoms in adults with major depressive disorder who have acute suicidal thoughts or behavior. And the most recent change came in January 2025, when the FDA added standalone use for treatment-resistant depression, as the current prescribing information shows.

‍

Every dose happens in a certified healthcare setting under the Spravato REMS, an FDA-required safety program. Each device delivers 28 mg, and a session uses two or three devices (56 or 84 mg), with a five-minute wait after each one. You're then monitored for at least two hours, and you can't drive again until the next day, once you've had a restful night's sleep. The label sets the early schedule: twice a week for weeks one through four, once a week for weeks five through eight, then weekly or every two weeks, adjusted to the least frequent dosing that maintains the response.

What Is Ketamine Infusion Therapy?

A ketamine infusion uses standard ketamine, both mirror-image forms together, delivered through an IV line. Ketamine has been FDA-approved as an anesthetic since 1970, but for depression, IV ketamine "remains an off-label treatment," in the Mayo Clinic review's words. Off-label prescribing is legal and common in medicine. It also means there is no FDA-approved depression regimen, so dosing schedules and safety protocols are set by each clinic.

‍

The most studied dose is 0.5 mg per kilogram of body weight, infused over about 40 minutes with continuous heart and blood pressure monitoring. A first course typically runs two to three infusions a week for about three to six treatments, followed by maintenance sessions on a schedule that varies from clinic to clinic.

Spravato vs Ketamine Infusion: Side-by-Side Comparison

Efficacy: What the Research Shows

The most complete head-to-head evidence is the 2025 Mayo Clinic meta-analysis in Therapeutic Advances in Psychopharmacology. The authors identified eight studies with 978 patients in total. Only one was a randomized trial, and it compared IV ketamine with an IV form of esketamine rather than the nasal spray, so the pooled comparison rests on observational studies of IV ketamine versus nasal esketamine.

‍

In those studies, the odds of response were 1.26 times higher with IV ketamine and the odds of remission 1.31 times higher, but neither difference was statistically significant. The authors concluded that the evidence suggests no significant difference in short-term efficacy, with a slight numerical trend favoring IV ketamine.

‍

Speed may be where the two differ. In one Mayo Clinic observational study included in the review, people reached remission after a median of two IV ketamine treatments, compared with seven nasal esketamine treatments. That's a real gap in lived experience. But it comes from observational data, where the people who choose or can access each treatment may differ in ways a study can't fully account for.

‍

So is Spravato better than ketamine infusions? On current evidence, neither has been shown to be. A randomized trial built to settle the question, called EQUIVALENCE, plans to assign 400 people to one treatment or the other for eight sessions over four weeks. Its protocol was published in 2026, and results are not yet available.

FDA Approval and Insurance Coverage

FDA approval changes who pays. Because Spravato has approved indications, insurers can write coverage criteria around it, and they typically require prior authorization and documentation of earlier antidepressant trials. Ketamine infusions for depression are off-label, so coverage is inconsistent, and many people pay out of pocket.

‍

The Spravato vs ketamine cost comparison has a twist. Economic modeling cited in the Mayo Clinic review found nasal esketamine unlikely to be cost-effective compared with IV ketamine from a health-system perspective. Yet an individual patient's out-of-pocket cost for Spravato may be lower, thanks to insurance coverage or manufacturer assistance. Published price estimates vary too widely by dose, frequency, and coverage to quote a single figure, so ask each provider and your insurer for the numbers that apply to you.

Side Effects and Safety Considerations

Because both drugs act on the same receptor, their side effects overlap. In Spravato's clinical trials, 48% to 61% of people developed sedation, and 61% to 84% experienced dissociative or perceptual changes, such as distortions of time or space, according to the prescribing information. Dizziness, nausea, vertigo, anxiety, and a temporary rise in blood pressure are also common, which is why blood pressure is rechecked about 40 minutes after dosing. IV ketamine produces the same family of effects, concentrated during and shortly after the infusion.

‍

Direct safety comparisons are limited. In one retrospective analysis included in the Mayo Clinic review, a rise in blood pressure during treatment occurred in 45% of IV ketamine patients versus 9.2% of nasal esketamine patients, and dissociative effects were also more frequent with IV ketamine, though they were described as transient. That is one retrospective study. It doesn't establish either drug as safer overall.

‍

Both drugs carry a potential for misuse, which shapes who is a candidate, and each has its own exclusions. Spravato, for example, isn't used in people with aneurysmal blood vessel disease, an arteriovenous malformation, or a history of bleeding in the brain.

What Influences the Choice Between Them

There isn't a universal right answer. A psychiatrist weighing the two usually considers:

‍

• Coverage and cost. Whether insurance will cover Spravato in your situation, and whether infusions are affordable out of pocket.
• How quickly relief is needed. Early data suggest infusions may reach remission in fewer sessions, which matters more when symptoms are severe.
• Medical history. Blood pressure, vascular conditions, and any history of substance misuse.
• Route. Some people would rather avoid an IV line. Others prefer an infusion that can be slowed or stopped.
• Logistics. Spravato means at least two hours in the clinic and no driving until the next day, twice a week at first. Infusions take about 40 minutes, plus recovery time that varies by clinic.
• Continuity. Whether you're already established with a psychiatrist or clinic that offers one of them.

‍

The choice belongs in a conversation with a psychiatrist who knows your treatment history, not in a ranking of favorites.

Making the Decision With a Psychiatrist

Spravato and ketamine infusions are tools for treatment-resistant depression, not a complete plan. They work alongside medication, therapy, and ongoing psychiatric care, and they sit among other options, including TMS therapy for depression that hasn't responded to medication. When depression brings thoughts of suicide, care for suicidal thoughts comes first.

‍

We don't offer Spravato at Amae. Our psychiatrists treat depression that hasn't responded to medication through our integrated care model, with therapy, medication management, and TMS, which we provide in Los Altos, San Mateo, and Los Angeles. Whether the question is Spravato vs ketamine infusion or something else entirely, talk through your options with an Amae psychiatrist, including ones we don't provide ourselves. For anyone in crisis right now, 988 is a call or text away.

Frequently Asked Questions

Is Spravato more effective than ketamine infusions?

Not on current evidence. A 2025 meta-analysis found no statistically significant difference in response or remission between IV ketamine and nasal esketamine, only a slight numerical trend favoring IV ketamine. Most of that evidence is observational, and a large randomized head-to-head trial is still underway.

Which works faster, Spravato or ketamine infusions?

IV ketamine may reach remission in fewer sessions. In one observational study, the median was two IV infusions versus seven nasal esketamine treatments. Because that finding comes from observational data rather than a randomized trial, treat it as preliminary.

Is Spravato safer than ketamine infusions?

Neither has been established as safer overall. The two share a similar side-effect profile because they act on the same receptor. One retrospective comparison found more blood pressure spikes and dissociation with IV ketamine, but a single study can't settle the question, and individual risk depends on your medical history.

Why is Spravato covered by insurance but ketamine infusions often aren't?

Spravato has FDA approval for treatment-resistant depression, which gives insurers defined criteria for covering it, usually with prior authorization. IV ketamine for depression is off-label, so coverage is inconsistent and infusions are often self-pay.

Can I switch between Spravato and ketamine infusions?

That's a clinical decision to make with a psychiatrist, based on how you've responded, the side effects you've had, your goals, and your coverage. It isn't something to change on your own.

How many sessions does each treatment typically require?

Spravato starts at twice a week for four weeks, then weekly, then weekly or every two weeks based on response. Ketamine infusions often begin with three to six sessions given two to three times a week, followed by maintenance on a schedule that varies by clinic.

‍

Citations

1. Elmosalamy A, Tarikogullari I, Patarroyo-Rodriguez L, et al. Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12615959/ (Tier 1)
2. U.S. Food and Drug Administration. SPRAVATO (esketamine) nasal spray prescribing information, revised January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf (Tier 2)
3. Wilkinson ST, Prashad S, Dalthorp R, et al. Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: the EQUIVALENCE trial protocol. Contemporary Clinical Trials. 2026;164:108273. https://pubmed.ncbi.nlm.nih.gov/41780747/ (Tier 1, trial protocol)
4. 988 Suicide and Crisis Lifeline. https://988lifeline.org (Tier 2)

‍

You hold it together at work. You're the one who remembers everyone's birthday, because you set four reminders for each. But the effort is constant, the to-do list never shrinks, and by evening there's nothing left. If that sounds familiar, you may be wondering whether ADHD symptoms in women could explain it, especially if no one ever suggested ADHD when you were a child.

ADHD in women often looks different from the hyperactive schoolboy most people picture. It tends to show up as inattention, mental restlessness, emotional overwhelm, and an exhausting amount of compensating. Many women aren't diagnosed until adulthood, after years of being told they're anxious, scattered, or just not trying hard enough.

What ADHD looks like in women

ADHD is a pattern of inattention and/or hyperactivity and impulsivity that makes it hard to function in at least two areas of life, such as home and work. The NIMH describes three types: inattentive, hyperactive-impulsive, and combined.

In girls and women, inattention often dominates. A 2014 review of ADHD in women and girls found that clinicians tend to see girls' symptoms as "subthreshold" because inattentiveness is more prominent than hyperactivity, and that girls may develop stronger coping strategies that mask their symptoms. That combination is a recipe for being overlooked.

It's common, too. In a 2023 national survey, an estimated 15.5 million U.S. adults, about 6.0%, reported a current ADHD diagnosis. Roughly half were diagnosed at 18 or older.

ADHD symptoms in women

ADHD symptoms in women are the same core symptoms anyone with ADHD has. What differs is how they show up and how well they're hidden.

Inattention and mental restlessness

• Losing the thread of conversations, meetings, or what you walked into a room for
• Starting many tasks and finishing few
• Losing keys, phones, and paperwork, then building elaborate systems to compensate
• A busy, noisy mind even when your body is still
• Zoning out during tasks that don't hold your interest

Time, organization, and follow-through

The NIMH notes that adults with ADHD often find it hard to stay organized, keep appointments, and complete large projects. In practice that looks like chronic lateness, piles of half-finished projects, and deadlines met only through last-minute panic.

Emotional intensity

Emotional dysregulation isn't one of the formal diagnostic criteria, but it's part of the picture for many women. An expert consensus statement published in BMC Psychiatry in 2020 noted that difficulties with emotional lability and dysregulation may be more severe or common in girls and women with ADHD. Small frustrations hit hard. Criticism lingers for days. Calming down takes longer than it should.

Impulsivity that's easy to miss

Impulsivity in women often looks less like risk-taking and more like interrupting, oversharing, saying yes to too much, or impulsive spending. It's real impulsivity. It just doesn't get flagged.

What "high-functioning ADHD" means

High-functioning ADHD isn't a diagnosis. You won't find it in the DSM-5. It's an informal way of describing someone whose ADHD symptoms are real and impairing, but hidden behind good grades, a solid job, or a well-run household.

The cost is the part nobody sees. The 2020 consensus statement points to the compensatory strategies that may mask or overshadow ADHD in women: over-preparing, perfectionism, rigid routines, working longer hours than colleagues to produce the same result. Those strategies work, until a new job, a baby, or a parent's illness pushes demands past what they can absorb. That's often when women first seek help.

"High-functioning" can also be misleading. Functioning well in one area doesn't mean functioning well in all of them. A woman can excel at work and still be overwhelmed at home, or keep her household running while her own health slips.

Is it ADD or ADHD?

"ADD" is an older, informal name that many people still use, especially for ADHD without obvious hyperactivity. Clinicians now use ADHD for all three types. What people usually mean by "ADD symptoms in women" is the inattentive type of ADHD: trouble focusing, organizing, and following through, without much visible restlessness.

Why ADHD in women gets missed

There are a few overlapping reasons:

• Quieter symptoms. Inattention is less disruptive than hyperactivity, so teachers and parents are less likely to refer a girl for evaluation.
• Masking. Coping strategies hide symptoms, sometimes from the woman herself.
• Other diagnoses first. The NIMH notes that ADHD often co-occurs with anxiety and depression, which can make each condition harder to diagnose and treat. Many women are treated for anxiety or depression for years before anyone considers ADHD. (We've written about how anxiety and depression overlap.)

The NIMH puts it plainly: ADHD symptoms in girls and women are especially likely to have been missed in childhood, and sex differences in diagnosis rates start to even out in adulthood. A 2023 systematic review in the Journal of Attention Disorders of women diagnosed as adults found recurring themes of strain on emotional wellbeing, difficult relationships, a sense of lack of control, and, after diagnosis, self-acceptance. For more on how presentations differ, see ADHD in women vs. men.

Hormones and ADHD symptoms

Many women notice their ADHD symptoms change across the month or at different life stages. Research is starting to catch up. A 2025 systematic review of 11 studies found evidence suggesting a link between sex hormones and ADHD symptoms in females, particularly during puberty and across the menstrual cycle. The authors called the evidence limited, with small samples, and noted that menopause has barely been studied.

If your symptoms seem to shift before your period or during perimenopause, you're not imagining it. Research just hasn't mapped those patterns well yet, so a symptom log gives a clinician more to work with than the studies do.

How ADHD is diagnosed in adults

There's no blood test or brain scan for ADHD. According to the NIMH, a diagnosis in adulthood requires:

• Symptoms that started before age 12, which is why clinicians ask about childhood and may want to talk to family members or see old school reports
• At least five symptoms of inattention or of hyperactivity and impulsivity (adults and teens over 16 need five, children six)
• Symptoms that cause problems in at least two areas of life

A careful evaluation also looks for conditions that mimic or accompany ADHD, especially anxiety, depression, sleep problems, and mood disorders. That step matters for women, who are more likely to arrive with one of those diagnoses already in their chart.

Treatment for ADHD in women

The most common treatments for adult ADHD, according to the NIMH, are medication (usually stimulants) and psychotherapy such as behavioral and cognitive behavioral therapy. Effective treatment often combines both, and some people need to try more than one approach. ADHD coaching can help with executive-function skills like planning and time management.

When ADHD comes with depression, anxiety, or bipolar disorder

For many women, ADHD isn't the whole story. It's the overlooked layer beneath years of depression, anxiety, or mood instability. When those conditions are severe or keep coming back despite treatment, getting the full picture right matters more than any single diagnosis.

At Amae Health, we treat complex mental health conditions, including Major Depressive Disorder and Bipolar Disorder, in integrated outpatient clinics. Our care teams bring psychiatrists, therapists, primary care physicians, and care coordinators under one roof, so a co-occurring condition like ADHD is considered as part of one treatment plan rather than in isolation. See how our integrated outpatient clinics work.

Frequently asked questions

What are the first signs of ADHD in women?

Common early signs include chronic disorganization, losing things, trouble finishing tasks, a restless mind, and feeling far more exhausted by everyday demands than peers seem to be. Many women recognize these patterns only in hindsight, often after a child is diagnosed or life demands increase.

Can you have ADHD and still be successful?

Yes. Many women with ADHD do well in school and work, often by compensating with extra effort, structure, and perfectionism. Success doesn't rule out ADHD. A clinician looks at impairment across areas of life and at how much effort functioning takes.

Is it ADHD or anxiety?

They can look alike and often occur together. Anxiety centers on worry and fear. ADHD centers on attention, organization, and impulsivity that have been present since childhood. Some women have both, and an evaluation should consider each.

Does ADHD get worse during perimenopause?

Some women notice that it does, and early research suggests hormones can affect ADHD symptoms. But studies on menopause are still very limited, so it isn't yet clear how common or predictable the change is.

How do I get tested for ADHD as an adult woman?

Start with a primary care provider or a psychiatrist who evaluates adults. Expect questions about childhood, current symptoms, and other conditions. Bringing old school reports or a family member who knew you as a child can help.

Key takeaways

• ADHD symptoms in women often center on inattention, mental restlessness, emotional intensity, and disorganization, rather than visible hyperactivity.
• "High-functioning ADHD" and "ADD" are informal terms. The diagnosis is ADHD, with three types.
• Masking and co-occurring anxiety or depression are two common reasons ADHD in women goes undiagnosed until adulthood.
• Diagnosis requires symptoms that began before age 12. Treatment usually combines medication, therapy, and skills support.

If ADHD has been sitting underneath depression, anxiety, or mood swings that haven't improved, you don't have to keep sorting through it alone. Request an intake appointment, and our team will explain how an evaluation works and what your first visit includes.

From the outside, you look fine. You show up, you apologize first, you keep your voice level. Inside, a small comment from a friend can set off hours of shame, a spiral of "they're going to leave," and a quiet decision to pull away before anyone can hurt you. That pattern has a name people search for: quiet BPD. It describes borderline personality disorder (BPD) turned inward, where the intense emotions are real but almost nobody sees them.

Quiet BPD isn't a separate diagnosis. It's a way of describing how BPD can look when anger, fear, and despair are directed at yourself instead of at other people. And because it's so easy to miss, people often live with it for years before anyone names it.

Is quiet BPD a real diagnosis?

Not formally. The DSM-5 describes one borderline personality disorder, with no official subtypes. "Quiet BPD," "silent BPD," "internalized BPD," and "hidden BPD" are informal terms that patients and clinicians use for the same inward-facing pattern.

The idea has roots in research, though. Psychologist Theodore Millon described four subtypes of BPD, including a "discouraged" type and a "petulant" type. The discouraged type, marked by avoidant and dependent traits, unexpressed anger, guilt, and shame, is the closest match to what people now call quiet BPD. (We've written separately about the outward-facing petulant type of BPD.)

Newer data points the same way. A 2023 study of 109 patients with BPD in a psychiatric day clinic, published in Personality Disorders: Theory, Research, and Treatment, sorted patients into three groups by symptom pattern. Thirty-five fit an "internalizing" profile, and that group had more co-occurring mood disorders than the others.

So the label is informal. The pattern is not.

Quiet BPD symptoms and signs

The core symptoms of quiet BPD are the same ones the NIMH lists for borderline personality disorder. What changes is the direction they travel.

• Fear of abandonment shows up as hypervigilance and pre-emptive withdrawal. You don't beg someone to stay. You leave first, or go silent, so the rejection can't land.
• Intense, shifting moods happen behind a calm face. An episode can last a few hours to a few days, and the people around you may never know it happened.
• Anger gets swallowed and turned into self-criticism. Instead of an outburst, there's a long internal prosecution of everything you did wrong.
• An unstable sense of self feels like not knowing who you are without someone else's approval, and shape-shifting to fit whoever you're with.
• Chronic emptiness can look like flatness or "I'm just tired" to everyone else.
• Dissociation, feeling cut off from yourself or your surroundings, often under stress.
• Rejection sensitivity: replaying a conversation for days, reading a short text as proof someone is done with you.
• Self-harm or suicidal thoughts, kept hidden.

People with this presentation are often described as perfectionists, people-pleasers, or "the easy one" in the family. That's part of why the condition goes unrecognized.

Quiet BPD vs. "classic" BPD

The difference isn't severity. It's visibility.

In the presentation most people picture, distress spills outward: arguments, accusations, impulsive spending or drinking, visible crises in relationships. In quiet BPD, the same emotional storm happens internally. The person who might shout "you never cared about me" instead thinks "of course they don't care, I'm too much," and quietly stops replying to messages.

Both reflect the same underlying difficulty regulating emotions. Both cause real suffering. One is just far easier to overlook.

Why quiet BPD gets missed

Quiet BPD often arrives in a clinic labeled as something else, usually depression or anxiety. The internal pattern of shame, emptiness, and withdrawal overlaps heavily with both, and BPD frequently co-occurs with them: the NIMH notes that people with BPD may also experience depression, anxiety disorders, PTSD, eating disorders, and substance use disorders. If you're treated for depression alone and keep cycling back, the underlying pattern may not have been named. (For more on that overlap, see how anxiety and depression overlap.)

There's a second reason. People with quiet BPD are skilled at appearing okay, including in a therapist's office. They minimize. They worry about being a burden. A clinician who only sees the composed surface can miss what's underneath.

What causes quiet BPD?

No single cause explains BPD, quiet or otherwise. Genes and environment both contribute.

On the genetic side, a 2021 study of more than 1.8 million people in Swedish national registries estimated the heritability of diagnosed BPD at 46%. Risk was highest among identical twins and fell as relatives became more distant. The remaining variance came from environmental factors unique to each person.

On the environmental side, clinicians often hear about childhoods where feelings were dismissed, punished, or simply never acknowledged. Some people learned early that expressing anger or need made things worse, so they stopped. That's one plausible route from a sensitive temperament to an inward-facing pattern, though research hasn't yet separated what makes one person's BPD quiet and another's outward.

Self-harm and safety

Quiet doesn't mean low-risk. The NIMH notes that people with BPD are more likely to engage in self-harm, and the inward-facing pattern makes it easier to hide. Families sometimes learn about self-harm or suicidal thoughts only after a crisis.

If you or someone you love is having thoughts of suicide, call or text the 988 Suicide & Crisis Lifeline at 988. In an emergency, call 911.

Treatment for quiet BPD

BPD is treatable, and the evidence is strongest for specialized psychotherapy. A 2020 Cochrane review pooled 75 randomized trials with 4,507 participants. Across 22 trials comparing psychotherapy with usual care, therapy reduced BPD symptom severity. The two most-studied approaches were:

• Dialectical behavior therapy (DBT), which was developed specifically for BPD and teaches skills for intense emotions, distress tolerance, and relationships.
• Mentalization-based treatment (MBT), which builds the ability to understand your own and other people's mental states, especially under stress.

For quiet BPD, part of the work is simply making the inner experience visible: learning to notice and name anger, shame, and fear before they turn into silent withdrawal.

Medication plays a supporting role. According to the NIMH, the benefits of medication for BPD are unclear and it isn't a first-line treatment. Clinicians may use it alongside therapy for specific symptoms or co-occurring conditions such as depression.

Can quiet BPD get better?

Yes. There's no long-term research on quiet BPD specifically, but the data on BPD overall is more hopeful than most people expect. In a 10-year study of 290 adults with BPD first assessed during a psychiatric hospital stay, published in the American Journal of Psychiatry in 2010, 93% reached a symptom remission lasting at least two years. Full recovery, meaning remission plus good work and social functioning, was harder: about half got there. That gap is the case for treatment that goes beyond symptoms to rebuild relationships, work, and daily life.

How we treat BPD at Amae Health

Borderline Personality Disorder is one of the conditions our clinics specialize in. Our care teams bring psychiatrists, therapists, primary care physicians, peer mentors, and care coordinators under one roof, working from one treatment plan. For someone with quiet BPD, that matters: the more people who know your history, the harder it is for a composed surface to hide what's going on. Read more about how we approach care.

Frequently asked questions

Is quiet BPD real?

Yes, as a pattern. "Quiet BPD" isn't an official DSM-5 diagnosis, but it describes a recognized way borderline personality disorder can present, close to the "discouraged" subtype Theodore Millon described and the "internalizing" group seen in newer research.

Is there a test for quiet BPD?

There's no validated test for quiet BPD specifically. Online quizzes can prompt reflection, but a BPD diagnosis comes from a clinical evaluation by a mental health professional who looks at your history, patterns over time, and co-occurring conditions.

How is quiet BPD different from depression?

They overlap and often occur together. Depression centers on low mood and loss of interest. Quiet BPD adds intense fear of abandonment, an unstable sense of self, rapid shifts in mood, and relationship patterns driven by rejection sensitivity.

How can I help someone with quiet BPD?

Notice withdrawal instead of reading it as disinterest, and ask directly how they're doing. Avoid pressing for an explanation in the moment. Our guide on how to help someone with mental health issues covers more. If they mention self-harm or suicide, take it seriously and contact 988.

Key takeaways

• Quiet BPD is an informal name for borderline personality disorder expressed inward: hidden anger, shame, withdrawal, and self-blame.
• It's not a separate DSM-5 diagnosis, but research has identified a similar "internalizing" pattern.
• It's often mistaken for depression or anxiety, and self-harm can stay hidden.
• Specialized psychotherapy such as DBT and MBT has the strongest evidence, and long-term remission is common.

If you recognize yourself here, or you're worried about someone who seems fine but isn't, you can request an intake appointment. Our team will explain how an evaluation works and what to expect from your first visit.